A multicenter phase 1 study of γ -secretase inhibitor RO4929097 in combination with capecitabine in refractory solid tumors
2014; Springer Science+Business Media; Volume: 33; Issue: 1 Linguagem: Inglês
10.1007/s10637-014-0166-6
ISSN1573-0646
AutoresNoelle K. LoConte, Albiruni R. Abdul Razak, Percy Ivy, Amyé Tevaarwerk, Rachael Leverence, Jill Kolesar, Lillian L. Siu, Sam Joseph Lubner, Daniel Mulkerin, William R. Schelman, Dustin A. Deming, Kyle D. Holen, Lakeesha Carmichael, Jens C. Eickhoff, Glenn Liu,
Tópico(s)Cancer Cells and Metastasis
Referência(s)